Malak AlThgafi, MD, MBA

Biography

Malak Abed AlThgafi, MD, MBA, is a professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. A board-certified pathologist, Dr. AlThgafi is a physician-scientist trained in clinical pathology, anatomical pathology, neuropathology and molecular genetics pathology and is an expert in the genomic profiling of tumors, particularly in neuro-oncology. She is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute of Emory University in Atlanta, Georgia. She is passionate about training the next generation of women physicians and scientists.

Titles & Roles

• Professor, Department of Pathology and Laboratory Medicine

  Emory University School of Medicine

Education & Training

Education

• Fellowship, Neuropathology, 2015

  Harvard Medical School
• Fellowship, Pathology-Molecular Genetic, 2013

  UCSF School of Medicine
• Fellowship, Pathology, 2012

  UCSF Medical Center at Mount Zion
• Residency, Pathology, 2011

  Georgetown Univ Hospital
• Medical Education, , 2005

  King Abdul Aziz UNiversity

Board Certifications

• Neuropathology

  American Board of Pathology, 2015
• Molecular Genetic Pathology

  American Board of Pathology, 2013

Professional Memberships

Dr. AlThgafi is a Fellow of the American College of Clinical Pathology and the American College of Pathologists. She holds professional memberships with the United States and Canadian Academy of Pathology, American College of Medical Genetics, Association for Molecular Pathology, American Medical Association and American Association for Neuropathologists.

Research

Dr. AlThgafi's research goal is to improve the application of personalized medicine and targeted therapy in the clinical management of patients with cancer.

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.